Neuro-Oncology Reviews
Volume
25 Number 6
31 March 2023
Home > Publications > Neuro-Oncology Reviews > Volume 25, Year 2023 > Number 6, 31 March
*
Arora S, Rathi AK, Singh K, Ansari FA.
Feasibility
of preirradiation temozolomide in cases of high-grade gliomas: Our
experience and review of literature.
J
Cancer Res Ther. 2023 Mar 16;19(2):221-227∟.
doi: 10.4103/jcrt.jcrt_942_21? PMID: 37006062∟.
Interventional study, Review. ˍ
Horowitz T, Tabouret E, Graillon T, Salgues B, Chinot O, Verger A,
Guedj E.
Contribution of nuclear
medicine to the diagnosis and management of primary brain
tumours.
Rev
Neurol (Paris). 2023 Mar 16:S0035-3787(23)00874-3∟.
doi: 10.1016/j.neurol.2023.03.002∟.
PMID: 36934021∟.
Review˰ ˍ
Kaurav M, Ruhi S, Al-Goshae HA, Jeppu AK, Ramachandran D, Sahu RK,
Sarkar AK, Khan J, Ashif Ikbal AM.
Dendrimer:
An update on recent developments and future opportunities for the
brain tumors diagnosis and treatment.
Front
Pharmacol. 2023 Mar 16;14:1159131∟.
doi: 10.3389/fphar.2023.1159131∟.
PMID: 37006997∟.
Review.
ˍ
*
Kimura S, Morita T, Hosoba K, Itoh H, Yamamoto T, Miyamoto
T.
Cholesterol in the ciliary membrane
as a therapeutic target against cancer.
Front
Mol Biosci. 2023 Mar 16;10:1160415∟.
doi: 10.3389/fmolb.2023.1160415∟.
PMID: 37006607∟.
Review.
ˍ
Shala AL, Arduino I, Salihu MB, Denora N.
Quercetin
and Its Nano-Formulations for Brain Tumor Therapy-Current
Developments and Future Perspectives for Paediatric
Studies.
Pharmaceutics.
2023 Mar 16;15(3):963∟.
doi: 10.3390/pharmaceutics15030963∟.
PMID: 36986827∟.
Review. ˍ
Yang Z, Zhao C, Zong S, Piao J, Zhao Y, Chen X.
A
review on surgical treatment options in gliomas.
Front
Oncol. 2023 Mar 16;13:1088484∟.
doi: 10.3389/fonc.2023.1088484∟.
PMID: 37007123∟.
Review.
ˍ
Abed T, Ganser K, Eckert F, Stransky N, Huber SM.
Ion
channels as molecular targets of glioblastoma
electrotherapy.
Front
Cell Neurosci. 2023 Mar 17;17:1133984∟.
doi: 10.3389/fncel.2023.1133984∟.
PMID: 37006466∟.
Review.
ˍ
Vetrano IG, Alongi P, Gatti
L.
Editorial:
Improving our understanding of the management and pathogenesis of
rare and neglected tumors of the central and peripheral nervous
system.
Front
Oncol. 2023 Mar 17;13:1162728∟.
doi: 10.3389/fonc.2023.1162728∟.
PMID: 37007150∟.
Editorial. ˍ
Lo HW, Tapinos N.
Editorial:
Epigenetics and cellular plasticity in glioblastoma.
Front
Oncol. 2023 Mar 20;13:1179214∟.
doi: 10.3389/fonc.2023.1179214∟.
PMID: 37020873∟.
Editorial. ˍ
Lovibond S, Gewirtz AN, Pasquini L, Krebs S, Graham MS.
The
promise of metabolic imaging in diffuse midline glioma.
Neoplasia.
2023 Mar 20;39:100896∟.
doi: 10.1016/j.neo.2023.100896∟.
PMID: 36944297∟.
Review. ˍ
Mittelbronn M.
Neurooncology: 2023
update.
Free
Neuropathol. 2023 Mar 20;4:4-4∟.
doi: 10.17879/freeneuropathology-2023-4692∟.
PMID: 37283935∟.
Perspective. ˍ
Nafe R, Porto L, Samp PF, You SJ, Hattingen E.
Adult-type
and Pediatric-type Diffuse Gliomas : What the Neuroradiologist
Should Know.
Clin
Neuroradiol. 2023 Mar 20∟.
doi: 10.1007/s00062-023-01277-z∟.
PMID: 36941392∟.
Review. ˍ
Del Baldo G, Del Bufalo F, Pinacchio C, Carai A, Quintarelli C, De
Angelis B, Merli P, Cacchione A, Locatelli F, Mastronuzzi A.
The
peculiar challenge of bringing CAR-T cells into the brain:
Perspectives in the clinical application to the treatment of
pediatric central nervous system tumors.
Front
Immunol. 2023 Mar 21;14:1142597∟.
doi: 10.3389/fimmu.2023.1142597∟.
PMID: 37025994∟.
Review.
ˍ
Orozco-Mera J, Peralta-Pizza F, Escobar-Vidarte O, Coll-Tello B,
Ariza A.
Signaling Pathways in the
Relapse of Glioblastoma.
Oncology
(Williston Park). 2023 Mar 21;37(3):107-117∟.
doi: 10.46883/2023.25920986∟.
PMID: 36961958∟.
Review. ˍ
Brisson L, Henrique Geraldo L, Bikfalvi A, Mathivet T.
The
strange Microenvironment of Glioblastoma.
Rev
Neurol (Paris). 2023 Mar 22:S0035-3787(23)00883-4∟.
doi: 10.1016/j.neurol.2023.03.007∟.
PMID: 36964121∟.
Review˰
ˍ
Morales-Suárez-Varela M, Llopis-Morales A, Doccioli C,
Donzelli G.
Relationship between
parental exposure to radiofrequency electromagnetic fields and
primarily hematopoietic neoplasms (lymphoma, leukemia) and tumors
in the central nervous system in children: a systematic
review.
Rev
Environ Health. 2023 Mar 22∟.
doi: 10.1515/reveh-2022-0248∟.
PMID: 36944196∟.
Review˰ ˍ
Suppree JS, Patel A, Keshwara SM, Krishna ST, Gillespie CS,
Richardson GE, Mustafa MA, Hart S, Islim AI, Jenkinson MD,
Millward CP.
Assessing the reporting
quality of adult neuro-oncology protocols, abstracts, and trials:
Adherence to the SPIRIT and CONSORT statements.
Neurooncol
Pract. 2023 Mar 22;10(4):391-401∟.
doi: 10.1093/nop/npad017∟.
PMID: 37457230∟.
Review˰ ˍ
Neumaier F, Zlatopolskiy BD, Neumaier B.
Mutated
Isocitrate Dehydrogenase (mIDH) as Target for PET Imaging in
Gliomas.
Molecules.
2023 Mar 23;28(7):2890∟.
doi: 10.3390/molecules28072890∟.
PMID: 37049661∟.
Review.
ˍ
Caverzán MD, Beaugé L, Oliveda PM, Cesca González
B, Bühler EM, Ibarra LE.
Exploring
Monocytes-Macrophages in Immune Microenvironment of Glioblastoma
for the Design of Novel Therapeutic Strategies.
Brain
Sci. 2023 Mar 24;13(4):542∟.
doi: 10.3390/brainsci13040542∟.
PMID: 37190507∟.
Review. ˍ
Ius T, Sabatino G, Panciani PP, Fontanella MM, Rudà R,
Castellano A, Barbagallo GMV, Belotti F, Boccaletti R, Catapano G,
Costantino G, Della Puppa A, Di Meco F, Gagliardi F, Garbossa D,
Germanò AF, Iacoangeli M, Mortini P, Olivi A, Pessina F,
Pignotti F, Pinna G, Raco A, Sala F, Signorelli F, Sarubbo S,
Skrap M, Spena G, Somma T, Sturiale C, Angileri FF, Esposito
V.
Surgical management of Glioma Grade
4: technical update from the neuro-oncology section of the Italian
Society of Neurosurgery (SINch®): a systematic review.
J
Neurooncol. 2023 Mar 24∟.
doi: 10.1007/s11060-023-04274-x∟.
PMID: 36961622∟.
Review. ˍ
Kurdi M, Mulla N, Malibary H, Bamaga AK, Fadul MM, Faizo E, Hakamy
S, Baeesa S.
Immune microenvironment of
medulloblastoma: The association between its molecular subgroups
and potential targeted immunotherapeutic receptors.
World
J Clin Oncol. 2023 Mar 24;14(3):117-130∟.
doi: 10.5306/wjco.v14.i3.117∟.
PMID: 37009528∟.
Review.
ˍ
Marcus R.
What Is Glioblastoma?
JAMA.
2023 Mar 24∟.
doi: 10.1001/jama.2023.2234∟.
PMID: 36961473∟.
Educational. ˍ
*
Silvani A.
New perspectives: glioma in
adult patients.
Tumori.
2023 Mar 24:3008916231159716∟.
doi: 10.1177/03008916231159716∟.
PMID: 36964665∟.
Editorial. ˍ
Kusaczuk M, Zhang X.
Editorial:
Targeting glioblastoma: Mechanisms of pathology and novel
therapeutic strategies.
Front
Mol Biosci. 2023 Mar 27;10:1181398∟.
doi: 10.3389/fmolb.2023.1181398∟.
PMID: 37051320∟.
Editorial. ˍ
Frosina G.
Recapitulating the Key
Advances in the Diagnosis and Prognosis of High-Grade Gliomas:
Second Half of 2021 Update.
Int
J Mol Sci. 2023 Mar 28;24(7):6375∟.
doi: 10.3390/ijms24076375∟.
PMID: 37047356∟.
Review.
ˍ
Gan HK, Day BW, Harrup R, Johns TG, Lwin Z, Scott AM, Sim HW, Koh
ES.
Clinical Trials in the Brain Tumour
Population: Challenges and Strategies for the Future.
Curr
Oncol Rep. 2023 Mar 28∟.
doi: 10.1007/s11912-023-01394-5∟.
PMID: 36976462∟.
Review˰ ˍ
Mahajan S, Schmidt MHH, Schumann U.
The
Glioma Immune Landscape: A Double-Edged Sword for Treatment
Regimens.
Cancers
(Basel). 2023 Mar 28;15(7):2024∟.
doi: 10.3390/cancers15072024∟.
PMID: 37046685∟.
Review.
ˍ
Bosio A, Lombardi G.
Recurrent
Glioblastoma: What Is the Route?
Cancers
(Basel). 2023 Mar 29;15(7):2028∟.
doi: 10.3390/cancers15072028∟.
PMID: 37046689∟.
Editorial. ˍ
*
Loras A, Gonzalez-Bonet LG, Gutierrez-Arroyo JL, Martinez-Cadenas
C, Marques-Torrejon MA.
Neural Stem
Cells as Potential Glioblastoma Cells of Origin.
Life
(Basel). 2023 Mar 29;13(4):905∟.
doi: 10.3390/life13040905∟.
PMID: 37109434∟.
Review. ˍ
*
Motomura K, Kibe Y, Ohka F, Aoki K, Yamaguchi J, Saito R.
Clinical
characteristics and radiological features of glioblastoma,
IDH-wildtype, grade 4 with histologically lower-grade
gliomas.
Brain Tumor
Pathol. 2023 Mar 29∟.
doi: 10.1007/s10014-023-00458-5∟.
PMID: 36988764∟.
Review˰ ˍ
Zhou Y, Xing X, Zhou J, Jiang H, Cen P, Jin C, Zhong Y, Zhou R,
Wang J, Tian M, Zhang H.
Therapeutic
potential of tumor treating fields for malignant brain
tumors.
Cancer Rep
(Hoboken). 2023 Mar 29:e1813∟.
doi: 10.1002/cnr2.1813∟.
PMID: 36987739∟.
Review. ˍ
Mengide JP, Berros MF, Turza ME, Liñares JM.
Posterior
fossa tumors in children: An update and new concepts.
Surg
Neurol Int. 2023 Mar 31;14:114∟.
doi: 10.25259/SNI_43_2023∟.
PMID: 37151431∟.
Review. ˍ
Metz MC, Wiestler B.
Molecular
imaging of gliomas.
Clin
Neuropathol. 2023 Mar 31∟.
doi: 10.5414/NP301535∟.
PMID: 36999510∟.
Review˰ ˍ
Nair SM, Sahu A, Dasgupta A,
Puranik A, Gupta T.
Post-ictal
changes presenting as late pseudoprogression on MRI and PET in a
patient with diffuse glioma: Case report and brief literature
review.
Neuroradiol
J. 2023 Mar 31;19714009231166105∟.
doi: 10.1177/19714009231166105∟.
PMID: 37002537∟.
Case report, Review˰ ˍ